Insider transactions

EDGAR

SOPHiA GENETICS SA

Transactions reported by directors, officers and 10% owners on SEC Forms 3, 4 and 5, read from each filing’s XML. Codes and their wording are the SEC’s own.

A Form 4 is due within two business days of the transaction, so the most recent trades may not be filed yet.

Window: transactions dated on or after 2025-11-21.

Open-market purchases (code P)
3 transactions, 60,000 shares
Sum of shares × price per share: 377,388
Open-market sales (code S)
156 transactions, 861,248 shares
Sum of shares × price per share: 5,385,171.0664

Totals add the filed transactions listed; they are counts of what was reported, not a measure of direction.

Showing 1–50 of 219

Insider transactions, newest first, as filed on SEC Forms 3, 4 and 5
DateReporting ownerCodeAcquired or disposedSharesPrice per share, as filedValue (derived)Shares owned afterDirect or indirectRule 10b5-1 boxNotesSource
2026-11-16 Filed 2026-11-17Van Well Daan Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)1,2247.7301
9,461.6424

Derived: shares × price per share. Exact value 9461.6424.

330,081Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.43 to $8.10, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000364 Read from the filing’s XML Dispute this row
2026-11-13 Filed 2026-11-16Xu Zhenyu Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)4,0007.9553
31,821.2

Derived: shares × price per share. Exact value 31821.2000.

537,493Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.67 to $8.27, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000362 Read from the filing’s XML Dispute this row
2026-11-12 Filed 2026-11-16Menu Philippe Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)5,0007.6799
38,399.5

Derived: shares × price per share. Exact value 38399.5000.

190,993Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.21 to $7.92, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000361 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-12HIBBS KATHY L Director
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)6,2507.7563
48,476.875

Derived: shares × price per share. Exact value 48476.8750.

90,742Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.52 to $7.89, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000358 Read from the filing’s XML Dispute this row
2026-11-10 Filed 2026-11-12Camblong Jurgi Director · Officer: Executive Chairman
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)8,5007.7586
65,948.1

Derived: shares × price per share. Exact value 65948.1000.

3,378,650Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.52 to $7.89, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000357 Read from the filing’s XML Dispute this row
2026-11-09 Filed 2026-11-12Van Well Daan Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)1,4117.4355
10,491.4905

Derived: shares × price per share. Exact value 10491.4905.

331,305Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.31 to $7.59, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000356 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-09Muken Ross Director · Officer: Chief Executive Officer
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)20,0006.8594
137,188

Derived: shares × price per share. Exact value 137188.0000.

680,391Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.70 to $7.08, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000351 Read from the filing’s XML Dispute this row
2026-11-06 Filed 2026-11-09CARDOZA GEORGE Officer: Chief Financial Officer
P

Open market or private purchase of non-derivative or derivative security

Ordinary Shares
Acquired (A)20,0007.06
141,200

Derived: shares × price per share. Exact value 141200.00.

326,726Direct (D) No
F1
  • F1 The price reported in Column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $6.74 to $7.12, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares purchased at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000352 Read from the filing’s XML Dispute this row
2026-10-13 Filed 2026-10-14Xu Zhenyu Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)4,0007.1818
28,727.2

Derived: shares × price per share. Exact value 28727.2000.

541,493Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.09 to $7.24, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000343 Read from the filing’s XML Dispute this row
2026-10-12 Filed 2026-10-14Camblong Jurgi Director · Officer: Executive Chairman
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)8,5007.2554
61,670.9

Derived: shares × price per share. Exact value 61670.9000.

3,387,150Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.15 to $7.38, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000340 Read from the filing’s XML Dispute this row
2026-10-12 Filed 2026-10-14Menu Philippe Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)5,0007.2606
36,303

Derived: shares × price per share. Exact value 36303.0000.

195,993Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.17 to $7.38, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000344 Read from the filing’s XML Dispute this row
2026-10-05 Filed 2026-10-07Valente Manuela Officer: Chief People Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)4,2408.1338
34,487.312

Derived: shares × price per share. Exact value 34487.3120.

206,210Direct (D) Yes
F1, F2
  • F1 Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on October 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.99 to $8.31, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000335 Read from the filing’s XML Dispute this row
2026-10-05 Filed 2026-10-07CARDOZA GEORGE Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)1,5928.1014
12,897.4288

Derived: shares × price per share. Exact value 12897.4288.

306,726Direct (D) Yes
F1, F2
  • F1 Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on October 2, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.00 to $8.23, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000332 Read from the filing’s XML Dispute this row
2026-10-05 Filed 2026-10-07Muken Ross Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)9,8388.1288
79,971.1344

Derived: shares × price per share. Exact value 79971.1344.

660,391Direct (D) Yes
F1, F2
  • F1 Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on October 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.91 to $8.34, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000328 Read from the filing’s XML Dispute this row
2026-10-05 Filed 2026-10-07Camblong Jurgi Director · Officer: Executive Chairman
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)40,1728.1282
326,526.0504

Derived: shares × price per share. Exact value 326526.0504.

3,395,650Direct (D) Yes
F1, F2
  • F1 Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on October 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.90 to $8.35, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000330 Read from the filing’s XML Dispute this row
2026-10-05 Filed 2026-10-07Puylaert Kevin Officer: Chief Sales Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)1858.06
1,491.1

Derived: shares × price per share. Exact value 1491.10.

147,763Direct (D) No
F1
  • F1 Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on October 2, 2026.
Open filing 0001840706-26-000333 Read from the filing’s XML Dispute this row
2026-10-05 Filed 2026-10-07Puylaert Kevin Officer: Chief Sales Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)317.92
245.52

Derived: shares × price per share. Exact value 245.52.

147,732Direct (D) No
F2
  • F2 Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on October 3, 2026.
Open filing 0001840706-26-000333 Read from the filing’s XML Dispute this row
2026-10-05 Filed 2026-10-07Xu Zhenyu Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)7,3948.1248
60,074.7712

Derived: shares × price per share. Exact value 60074.7712.

545,493Direct (D) Yes
F1, F2
  • F1 Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on October 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.99 to $8.30, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000329 Read from the filing’s XML Dispute this row
2026-10-05 Filed 2026-10-07Van Well Daan Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)6,1688.1226
50,100.1968

Derived: shares × price per share. Exact value 50100.1968.

332,716Direct (D) Yes
F1, F2
  • F1 Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on October 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.91 to $8.30, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000336 Read from the filing’s XML Dispute this row
2026-10-05 Filed 2026-10-07Verma Abhimanyu Officer: Chief Technology Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)5,2848.1243
42,928.8012

Derived: shares × price per share. Exact value 42928.8012.

166,887Direct (D) Yes
F1, F2
  • F1 Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on October 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.91 to $8.30, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000334 Read from the filing’s XML Dispute this row
2026-10-05 Filed 2026-10-07Menu Philippe Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)7,3948.1282
60,099.9108

Derived: shares × price per share. Exact value 60099.9108.

200,993Direct (D) Yes
F1, F2
  • F1 Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on October 2 and 3, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.91 to $8.30, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000331 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-22CARDOZA GEORGE Officer: Chief Financial Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)7748.33
6,447.42

Derived: shares × price per share. Exact value 6447.42.

308,318Direct (D) Yes
F1
  • F1 Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on September 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
Open filing 0001840706-26-000318 Read from the filing’s XML Dispute this row
2026-09-21 Filed 2026-09-22Muken Ross Director · Officer: Chief Executive Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)4228.33
3,515.26

Derived: shares × price per share. Exact value 3515.26.

670,229Direct (D) Yes
F1
  • F1 Represents shares sold by the Reporting Person in the open market to satisfy tax withholding obligations arising in connection with the vesting of restricted stock units on September 18, 2026. These sales were effected pursuant to a pre-established Rule 10b5-1(c) trading plan adopted by the Reporting Person and do not represent discretionary trades.
Open filing 0001840706-26-000317 Read from the filing’s XML Dispute this row
2026-09-14 Filed 2026-09-16Xu Zhenyu Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)4,0007.8844
31,537.6

Derived: shares × price per share. Exact value 31537.6000.

552,887Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.78 to $7.99, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000313 Read from the filing’s XML Dispute this row
2026-09-14 Filed 2026-09-16Menu Philippe Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)5,0007.8833
39,416.5

Derived: shares × price per share. Exact value 39416.5000.

208,387Direct (D) No
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.78 to $7.99, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000314 Read from the filing’s XML Dispute this row
2026-09-11 Filed 2026-09-14Van Well Daan Officer: Chief Legal Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)6,1687.6344
47,088.9792

Derived: shares × price per share. Exact value 47088.9792.

338,884Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.55 to $7.85, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000310 Read from the filing’s XML Dispute this row
2026-09-10 Filed 2026-09-14Camblong Jurgi Director · Officer: Executive Chairman
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)8,5007.6612
65,120.2

Derived: shares × price per share. Exact value 65120.2000.

3,435,822Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.57 to $7.79, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000309 Read from the filing’s XML Dispute this row
2026-09-08 Filed 2026-09-10HIBBS KATHY L Director
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)6,2508.1308
50,817.5

Derived: shares × price per share. Exact value 50817.5000.

96,992Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.90 to $8.35, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000306 Read from the filing’s XML Dispute this row
2026-08-27 Filed 2026-08-31Xu Zhenyu Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)10,0008.9096
89,096

Derived: shares × price per share. Exact value 89096.0000.

556,887Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.90 to $8.92, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000304 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-26Menu Philippe Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)5,0008.6793
43,396.5

Derived: shares × price per share. Exact value 43396.5000.

213,387Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.37 to $8.84, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000302 Read from the filing’s XML Dispute this row
2026-08-25 Filed 2026-08-26HIBBS KATHY L Director
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)6,2508.6773
54,233.125

Derived: shares × price per share. Exact value 54233.1250.

103,242Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.31 to $8.83 inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000301 Read from the filing’s XML Dispute this row
2026-08-24 Filed 2026-08-26Verma Abhimanyu Officer: Chief Technology Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)5,0008.80
44,000

Derived: shares × price per share. Exact value 44000.00.

172,171Direct (D) Yes
F1
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
Open filing 0001840706-26-000298 Read from the filing’s XML Dispute this row
2026-08-21 Filed 2026-08-21Xu Zhenyu Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)5,4088.4036
45,446.6688

Derived: shares × price per share. Exact value 45446.6688.

566,887Direct (D) Yes
F1, F4
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F4 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.40 to $8.42, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000292 Read from the filing’s XML Dispute this row
2026-08-20 Filed 2026-08-21Xu Zhenyu Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)4,5928.4078
38,608.6176

Derived: shares × price per share. Exact value 38608.6176.

572,295Direct (D) Yes
F1, F3
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $8.40 to $8.43, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000292 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-26Verma Abhimanyu Officer: Chief Technology Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)5,0008.20
41,000

Derived: shares × price per share. Exact value 41000.00.

177,171Direct (D) Yes
F1
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
Open filing 0001840706-26-000298 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21Xu Zhenyu Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)10,0007.9427
79,427

Derived: shares × price per share. Exact value 79427.0000.

576,887Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.90 to $8.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000292 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21Valente Manuela Officer: Chief People Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Ordinary Shares
Acquired (A)10,0003.20
32,000

Derived: shares × price per share. Exact value 32000.00.

220,450Direct (D) Yes
F1
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
Open filing 0001840706-26-000293 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21Valente Manuela Officer: Chief People Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)10,0007.9439
79,439

Derived: shares × price per share. Exact value 79439.0000.

210,450Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.90 to $8.01, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000293 Read from the filing’s XML Dispute this row
2026-08-19 Filed 2026-08-21Valente Manuela Officer: Chief People Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Share Option (Right to Buy) — underlying Ordinary Shares (10,000) — exercise price 3.20
Disposed (D)10,0000—0Direct (D) Yes
F1, F3, F4
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F3 The share options are fully vested and exercisable.
  • F4 Following the transaction reported on this line, the Reporting Person holds an aggregate total of 554, 276 derivative share options across all remaining grant tranches with varying exercise prices.
Open filing 0001840706-26-000293 Read from the filing’s XML Dispute this row
2026-08-13 Filed 2026-08-14Xu Zhenyu Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)4,0007.5191
30,076.4

Derived: shares × price per share. Exact value 30076.4000.

586,887Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.43 to $7.62, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000282 Read from the filing’s XML Dispute this row
2026-08-12 Filed 2026-08-14Menu Philippe Officer: Chief Medical Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)5,0007.5159
37,579.5

Derived: shares × price per share. Exact value 37579.5000.

218,387Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.40 to $7.60, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000283 Read from the filing’s XML Dispute this row
2026-08-10 Filed 2026-08-10Camblong Jurgi Director · Officer: Executive Chairman
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)8,5007.6081
64,668.85

Derived: shares × price per share. Exact value 64668.8500.

3,444,322Direct (D) Yes
F1, F3
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.50 to $7.80, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000278 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-10Verma Abhimanyu Officer: Chief Technology Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)5,0007.60
38,000

Derived: shares × price per share. Exact value 38000.00.

182,171Direct (D) Yes
F1
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
Open filing 0001840706-26-000279 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-10Camblong Jurgi Director · Officer: Executive Chairman
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)20,0007.227
144,540

Derived: shares × price per share. Exact value 144540.000.

3,452,822Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.20 to $7.27, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000278 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-07Xu Zhenyu Officer: Chief Scientific Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Ordinary Shares
Acquired (A)7,0003.28
22,960

Derived: shares × price per share. Exact value 22960.00.

607,887Direct (D) Yes
F1
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
Open filing 0001840706-26-000275 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-07Xu Zhenyu Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)7,0007.0217
49,151.9

Derived: shares × price per share. Exact value 49151.9000.

600,887Direct (D) Yes
F1, F2
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F2 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.00 to $7.08, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000275 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-07Xu Zhenyu Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)10,0007.4759
74,759

Derived: shares × price per share. Exact value 74759.0000.

590,887Direct (D) Yes
F1, F3
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
  • F3 The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $7.40 to $7.56, inclusive. The Reporting Person undertakes to provide to the issuer, any security holder of the issuer, or the staff of the Securities and Exchange Commission, upon written request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
Open filing 0001840706-26-000275 Read from the filing’s XML Dispute this row
2026-08-07 Filed 2026-08-07Xu Zhenyu Officer: Chief Scientific Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Derivative security: Share Option (Right to Buy) — underlying Ordinary Shares (7,000) — exercise price 3.28
Disposed (D)7,0003.28
22,960

Derived: shares × price per share. Exact value 22960.00.

0Direct (D) Yes
F4, F6
  • F4 The share options are fully vested and exercisable.
  • F6 Following the transaction reported on this line, the Reporting Person holds an aggregate total of 975,041 derivative share options across all remaining grant tranches with varying exercise prices.
Open filing 0001840706-26-000275 Read from the filing’s XML Dispute this row
2026-08-05 Filed 2026-08-07Xu Zhenyu Officer: Chief Scientific Officer
M

Exercise or conversion of derivative security exempted pursuant to Rule 16b-3

Ordinary Shares
Acquired (A)3,0003.28
9,840

Derived: shares × price per share. Exact value 9840.00.

603,887Direct (D) Yes
F1
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
Open filing 0001840706-26-000275 Read from the filing’s XML Dispute this row
2026-08-05 Filed 2026-08-07Xu Zhenyu Officer: Chief Scientific Officer
S

Open market or private sale of non-derivative or derivative security

Ordinary Shares
Disposed (D)3,0007.0043
21,012.9

Derived: shares × price per share. Exact value 21012.9000.

600,887Direct (D) Yes
F1
  • F1 Transaction made pursuant to duly adopted trading plan under Rule 10b5-1(c).
Open filing 0001840706-26-000275 Read from the filing’s XML Dispute this row

Institutional holders (Form 13F)

Quarter ending 2026-09-30: 8,935 filings read, the latest filed 2026-11-20. Prior quarter ending 2026-06-30: 9,178 filings read.

Showing 1–50 of 98

Institutional holders, largest position first, as filed
ManagerShares or principalValue as filedChange from the prior quarterSource
GENERATION INVESTMENT MANAGEMENT LLP 6,789,560 SH56,896,513 dollarsUnchanged Prior quarter: 6,789,560Open filing 0001752724-26-000065 Filed 2026-11-16 Dispute this row
ROYCE ASSOCIATES LP 3,887,743 SH32,579,286 dollarsHigher by 506,007 Prior quarter: 3,381,736Open filing 0000906304-26-000218 Filed 2026-11-09 Dispute this row
AKRE CAPITAL MANAGEMENT LLC 3,719,140 SH31,166,393 dollarsUnchanged Prior quarter: 3,719,140Open filing 0001112520-26-000022 Filed 2026-11-13 Dispute this row
AMERIPRISE FINANCIAL INC Partly reported under another manager2,831,050 SH23,724,219 dollarsHigher by 614,298 Prior quarter: 2,216,752Open filing 0001193125-26-463125 Filed 2026-11-16 Dispute this row
BANQUE PICTET CIE SA 2,208,280 SH18,505,386 dollarsUnchanged Prior quarter: 2,208,280Open filing 0001535602-26-000012 Filed 2026-10-16 Dispute this row
PRINCIPAL FINANCIAL GROUP INC Partly reported under another manager2,154,515 SH18,054,836 dollarsLower by 209,741 Prior quarter: 2,364,256Open filing 0001126328-26-000225 Filed 2026-11-02 Dispute this row
AWM Investment Company, Inc. 1,764,204 SH14,784,030 dollarsHigher by 64,204 Prior quarter: 1,700,000Open filing 0001535264-26-000061 Filed 2026-11-13 Dispute this row
AIGH Capital Management LLC Partly reported under another manager1,689,395 SH14,157,130 dollarsLower by 2,264,799 Prior quarter: 3,954,194Open filing 0001214659-26-013578 Filed 2026-11-02 Dispute this row
Point72 Asset Management, L.P. 1,566,684 SH13,128,812 dollarsNot in the prior quarter’s filings read Open filing 0000919574-26-008126 Filed 2026-11-16 Dispute this row
SILVERCREST ASSET MANAGEMENT GROUP LLC 1,423,965 SH11,932,827 dollarsLower by 4,505 Prior quarter: 1,428,470Open filing 0001193125-26-462346 Filed 2026-11-16 Dispute this row
Alta Wealth Advisors LLC 1,259,160 SH10,551,761 dollarsLower by 150,000 Prior quarter: 1,409,160Open filing 0002085853-26-001382 Filed 2026-11-12 Dispute this row
NEXT CENTURY GROWTH INVESTORS LLC 1,053,469 SH8,828,070 dollarsNot in the prior quarter’s filings read Open filing 0001134007-26-000007 Filed 2026-11-13 Dispute this row
TWO SIGMA INVESTMENTS, LP 1,040,627 SH8,720,454 dollarsHigher by 982,294 Prior quarter: 58,333Open filing 0000899140-26-001341 Filed 2026-11-16 Dispute this row
CITADEL ADVISORS LLC Partly reported under another manager746,052 SH6,251,916 dollarsHigher by 707,555 Prior quarter: 38,497Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
Walleye Capital LLC 685,960 SH5,748,345 dollarsHigher by 674,417 Prior quarter: 11,543Open filing 0001758720-26-000007 Filed 2026-11-13 Dispute this row
Ensign Peak Advisors, Inc 681,812 SH5,713,585 dollarsHigher by 237,158 Prior quarter: 444,654Open filing 0001454984-26-000011 Filed 2026-11-12 Dispute this row
ESSEX INVESTMENT MANAGEMENT CO LLC Partly reported under another manager643,129 SH5,389,421 dollarsLower by 20,299 Prior quarter: 663,428Open filing 0000201772-26-000007 Filed 2026-10-19 Dispute this row
JANE STREET GROUP, LLC Option: Call Partly reported under another manager448,100 SH3,755,078 dollarsHigher by 144,900 Prior quarter: 303,200Open filing 0001595888-26-000162 Filed 2026-11-12 Dispute this row
Hodges Capital Management Inc. 430,642 SH3,608,780 dollarsHigher by 21,569 Prior quarter: 409,073Open filing 0001337263-26-000007 Filed 2026-11-13 Dispute this row
MARSHALL WACE, LLP Partly reported under another manager393,812 SH3,300,144 dollarsNot in the prior quarter’s filings read Open filing 0001318757-26-000012 Filed 2026-11-13 Dispute this row
ACADIAN ASSET MANAGEMENT LLC Partly reported under another manager346,610 SH2,898 dollarsHigher by 324,010 Prior quarter: 22,600Open filing 0001140361-26-042753 Filed 2026-11-09 Dispute this row
Sowell Financial Services LLC 341,889 SH2,865,030 dollarsNot in the prior quarter’s filings read Open filing 0001633697-26-000007 Filed 2026-10-23 Dispute this row
MORGAN STANLEY Partly reported under another manager313,782 SH2,629,495 dollarsHigher by 276,285 Prior quarter: 37,497Open filing 0000895421-26-000309 Filed 2026-11-13 Dispute this row
GOLDMAN SACHS GROUP INC Partly reported under another manager292,278 SH2,449,290 dollarsHigher by 262,680 Prior quarter: 29,598Open filing 0000886982-26-000647 Filed 2026-11-16 Dispute this row
RENAISSANCE TECHNOLOGIES LLC Partly reported under another manager270,900 SH2,270,142 dollarsHigher by 157,600 Prior quarter: 113,300Open filing 0001037389-26-000062 Filed 2026-11-12 Dispute this row
Qube Research Technologies Ltd 269,565 SH2,258,955 dollarsNot in the prior quarter’s filings read Open filing 0001729829-26-000018 Filed 2026-11-13 Dispute this row
Bank Pictet Cie (Europe) AG 255,200 SH2,138,576 dollarsUnchanged Prior quarter: 255,200Open filing 0001123274-26-000008 Filed 2026-10-20 Dispute this row
FORMULA GROWTH LTD 254,000 SH2,128,520 dollarsNot in the prior quarter’s filings read Open filing 0001011438-26-000699 Filed 2026-11-13 Dispute this row
Jump Financial, LLC Partly reported under another manager223,777 SH1,875,251 dollarsNot in the prior quarter’s filings read Open filing 0000905148-26-004786 Filed 2026-11-13 Dispute this row
1492 Capital Management LLC 222,037 SH1,860,670 dollarsLower by 157 Prior quarter: 222,194Open filing 0001584087-26-000009 Filed 2026-11-12 Dispute this row
MILLENNIUM MANAGEMENT LLC 214,308 SH1,795,901 dollarsHigher by 75,899 Prior quarter: 138,409Open filing 0001273087-26-000011 Filed 2026-11-16 Dispute this row
SIMPLEX TRADING, LLC Option: Call 212,700 SH1,782,426 dollarsLower by 81,500 Prior quarter: 294,200Open filing 0001488542-26-000013 Filed 2026-11-04 Dispute this row
Squarepoint Ops LLC Partly reported under another manager195,696 SH1,639,932 dollarsNot in the prior quarter’s filings read Open filing 0001642575-26-000012 Filed 2026-11-09 Dispute this row
BANK OF AMERICA CORP /DE/ Partly reported under another manager190,367 SH1,595,275 dollarsHigher by 168,067 Prior quarter: 22,300Open filing 0000070858-26-000589 Filed 2026-11-16 Dispute this row
SUSQUEHANNA INTERNATIONAL GROUP, LLP Option: Call Partly reported under another manager185,200 SH1,551,976 dollarsHigher by 13,000 Prior quarter: 172,200Open filing 0001446194-26-000009 Filed 2026-11-16 Dispute this row
LPL Financial LLC 168,498 SH1,412,013 dollarsNot in the prior quarter’s filings read Open filing 0001403438-26-000005 Filed 2026-11-06 Dispute this row
TUDOR INVESTMENT CORP ET AL 152,886 SH1,281,185 dollarsNot in the prior quarter’s filings read Open filing 0000902664-26-004567 Filed 2026-11-16 Dispute this row
LANDSCAPE CAPITAL MANAGEMENT, L.L.C. Partly reported under another manager122,887 SH1,029,793 dollarsNot in the prior quarter’s filings read Open filing 0000919574-26-007537 Filed 2026-11-10 Dispute this row
FRANKLIN TEMPLETON INC Partly reported under another manager120,926 SH842,854 dollarsHigher by 98,521 Prior quarter: 22,405Open filing 0000038777-26-000291 Filed 2026-11-12 Dispute this row
EDMOND DE ROTHSCHILD HOLDING S.A. Partly reported under another manager120,004 SH1,005,634 dollarsLower by 80,000 Prior quarter: 200,004Open filing 0000947871-26-001003 Filed 2026-11-10 Dispute this row
Hennion Walsh Asset Management, Inc. 118,262 SH991,036 dollarsHigher by 19,915 Prior quarter: 98,347Open filing 0002000324-26-005579 Filed 2026-10-13 Dispute this row
CITADEL ADVISORS LLC Option: Call Partly reported under another manager112,400 SH941,912 dollarsLower by 36,300 Prior quarter: 148,700Open filing 0001104659-26-128228 Filed 2026-11-16 Dispute this row
BIT Capital GmbH 105,888 SH887,341 dollarsNot in the prior quarter’s filings read Open filing 0002053305-26-000009 Filed 2026-11-13 Dispute this row
HRT FINANCIAL LP 103,303 SH865 dollarsHigher by 80,771 Prior quarter: 22,532Open filing 0001475597-26-000249 Filed 2026-11-13 Dispute this row
SEI INVESTMENTS CO Partly reported under another manager102,234 SH856,719 dollarsLower by 62,811 Prior quarter: 165,045Open filing 0000350894-26-000059 Filed 2026-11-10 Dispute this row
Archon Capital Management LLC 84,733 SH710,063 dollarsLower by 606,680 Prior quarter: 691,413Open filing 0000919574-26-007832 Filed 2026-11-16 Dispute this row
GEODE CAPITAL MANAGEMENT, LLC 84,412 SH707,372 dollarsLower by 14,712 Prior quarter: 99,124Open filing 0001214717-26-000012 Filed 2026-11-06 Dispute this row
Steward Partners Investment Advisory, LLC 81,154 SH680,071 dollarsNot in the prior quarter’s filings read Open filing 0001723397-26-000006 Filed 2026-11-13 Dispute this row
Rathbones Group PLC 81,112 SH679,718 dollarsLower by 31,021 Prior quarter: 112,133Open filing 0001140361-26-043237 Filed 2026-11-12 Dispute this row
Silverberg Bernstein Capital Management LLC 77,989 SH653,548 dollarsHigher by 11,120 Prior quarter: 66,869Open filing 0002007880-26-000006 Filed 2026-10-13 Dispute this row
Managers in the prior quarter with no filing read for the latest

They may simply not have filed yet: absent from the latest quarter’s filings read is not the same as a position sold.

  • KENNEDY CAPITAL MANAGEMENT LLC 917,977 SH
  • Maven Securities LTD 150,000 SH
  • JANE STREET GROUP, LLC 108,062 SH
  • Longaeva Partners L.P. 50,000 SH
  • StoneX Group Inc. 45,523 SH
  • HEIGHTS CAPITAL MANAGEMENT, INC 20,000 SH
  • Centiva Capital, LP 18,869 SH
  • Persistent Asset Partners Ltd 18,807 SH
  • PRELUDE CAPITAL MANAGEMENT, LLC 15,596 SH
  • CoreCap Advisors, LLC 490 SH
  • Integrated Wealth Concepts LLC 122 SH
  • Form 13F covers long positions in Section 13(f) securities only: no short positions and no securities outside that list.
  • Reports for quarters ending before 2013-06-30 were filed as plain text and are not read.
  • A manager that has not yet filed for the latest quarter is absent, not at zero; filings are due up to 45 days after quarter end.
  • A change is the difference between two quarter-end snapshots, not a trade.
  • A position reported under another manager may also appear in that manager’s filing; rows are not added together.
  • Holdings the securities list cannot place with this company, or places ambiguously, are not shown.

Trades by members of Congress

Periodic transaction reports filed by U.S. House members that name this company’s stock. Dates and amounts are as filed.

No House member’s trade in this company is placed in the store. A trade not yet filed or not linked to a company is absent, not zero.

5% holders (Schedule 13D and 13G)

Schedules filed in the SEC’s structured format (late 2024 onward) are read here. Earlier schedules are free text and are not read.

5% holders, newest event first, as filed
HolderPercent of classShares heldEvent dateFormSource
Schindel Yair Chaim Ordinary Shares, par value CHF 0.05 per share6.25,318,023.0011/10/2026 Filed 2026-11-12SCHEDULE 13D/AAmendment 2Open filing 0001178913-26-005168 Dispute this row
aMoon Growth Fund Limited Partnership Ordinary Shares, par value CHF 0.05 per share6.25,318,023.0011/10/2026 Filed 2026-11-12SCHEDULE 13D/AAmendment 2Open filing 0001178913-26-005168 Dispute this row
aMoon Growth Fund G.P. Limited Partnership Ordinary Shares, par value CHF 0.05 per share6.25,318,023.0011/10/2026 Filed 2026-11-12SCHEDULE 13D/AAmendment 2Open filing 0001178913-26-005168 Dispute this row
aMoon General Partner Ltd. Ordinary Shares, par value CHF 0.05 per share6.25,318,023.0011/10/2026 Filed 2026-11-12SCHEDULE 13D/AAmendment 2Open filing 0001178913-26-005168 Dispute this row
aMoon Edge Limited Partnership Ordinary Shares, par value CHF 0.05 per share00.0011/10/2026 Filed 2026-11-12SCHEDULE 13D/AAmendment 2Open filing 0001178913-26-005168 Dispute this row
aMoon Edge GP Ltd. Ordinary Shares, par value CHF 0.05 per share00.0011/10/2026 Filed 2026-11-12SCHEDULE 13D/AAmendment 2Open filing 0001178913-26-005168 Dispute this row
Hilliyon Holdings Ltd. Ordinary Shares, par value CHF 0.05 per share00.0011/10/2026 Filed 2026-11-12SCHEDULE 13D/AAmendment 2Open filing 0001178913-26-005168 Dispute this row
Berko Capital Ltd. Ordinary Shares, par value CHF 0.05 per share00.0011/10/2026 Filed 2026-11-12SCHEDULE 13D/AAmendment 2Open filing 0001178913-26-005168 Dispute this row
Dr. Tomer Berkovitz Ordinary Shares, par value CHF 0.05 per share00.0011/10/2026 Filed 2026-11-12SCHEDULE 13D/AAmendment 2Open filing 0001178913-26-005168 Dispute this row
Balderton Capital VI, S.L.P. Ordinary Shares, CHF 0.05 per share4.93,301,24012/31/2025 Filed 2026-02-11SCHEDULE 13G/AAmendment 3Open filing 0000950130-26-000069 Dispute this row
AKRE CAPITAL MANAGEMENT, LLC Ordinary Shares, par value CHF 0.05 per share5.63,719,140.0006/20/2025 Filed 2025-06-27SCHEDULE 13GOpen filing 0000919574-25-003801 Dispute this row
Braddock Partners Offshore, LP Ordinary Shares, par value CHF 0.05 per share5.63,719,140.0006/20/2025 Filed 2025-06-27SCHEDULE 13GOpen filing 0000919574-25-003801 Dispute this row
Braddock Capital Offshore, LLC Ordinary Shares, par value CHF 0.05 per share5.63,719,140.0006/20/2025 Filed 2025-06-27SCHEDULE 13GOpen filing 0000919574-25-003801 Dispute this row

Percent is of the class the filing names, as the holder stated it. Members of a group each report the group’s shares, so rows are not added together.

What was read

2,755,423 filings read, dated 2004-06-14 to 2026-11-20: Forms 3, 3/A, 4, 4/A, 5, 5/A.

Years can be incomplete while the archive is still being read. A year with few filings here is not a statement that few were made.

Filings read, by filing year
Filing yearFilings read
2015171,805
2016222,642
2017222,009
2018223,345
2019216,482
2020226,343
2021249,835
2022231,682
2023229,674
2024234,045
2025235,520
2026263,828

Filings made before the SEC required XML are listed, not extracted.

Back to SOPHiA GENETICS SA